{"id":428759,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2018-01-04] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T00:32:11.662000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-19.html","snippet":"Notice: Prescription Drug List (PDL): Multiple Additions Janurary 4, 2018 Our reference number: 17-114235-356 The purpose of this Notice of Amendment is to notify about the additions of durvalumab, glycopyrrolate, letermovir, migalastat, netupitant/palonosetron hydrochloride to…","rawSnapshotUrl":"/api/snapshots/raw/428759","browseUrl":"https://replay.healtharchive.ca/job-6/20260102003211/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-19.html#ha_snapshot=428759","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}